SCOPUS 정보 검색 플랫폼

Journal of Controlled Release

Volumn 74, Issue 1-3, 2001, Pages 203-211

Synthesis and characterization of HPMA copolymer-aminopropylgeldanamycin conjugates

(6) Kasuya, Y a Lu, Z R a Kopeckova P a,b Minko, T a Tabibi, S E c Kopecek J a,b

a UNIVERSITY OF UTAH (United States)

b Department of Electrical and Computer Engineering (United States)

c NATIONAL CANCER INSTITUTE (United States)

Author keywords

Drug delivery system; Geldanamycin; Heat shock protein; HPMA copolymer; Ovarian carcinoma

Indexed keywords

17 (3 AMINOPROPYLAMINO) 17 DEMETHOXYGELDANAMYCIN; ANTIGEN OA 3; DOXORUBICIN; ESTER DERIVATIVE; GELDANAMYCIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY OV TL16; N (2 HYDROXYPROPYL)METHACRYLAMIDE COPOLYMER; N GLYCYLGLYCINE 4 NITROPHENYL ESTER; N METHYLACRYLOYLGLYCYLPHENYLALANYLGLYCYL 17 (3 AMINOPROPYLAMINO) 17 DEMETHOXYGELDANAMYCIN; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; BREAST ADENOCARCINOMA; CARCINOMA CELL; CELL VIABILITY; CONFERENCE PAPER; CONTROLLED STUDY; CYTOTOXICITY; DRUG ADSORPTION; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; IC 50; MASS SPECTROMETRY; NUCLEAR MAGNETIC RESONANCE; OVARY CARCINOMA; POLYMERIZATION; PRECIPITATION; PRIORITY JOURNAL; VALIDATION PROCESS;

ANTIBIOTICS, ANTINEOPLASTIC; ANTIBODIES, MONOCLONAL; BENZOQUINONES; DRUG CARRIERS; FEMALE; HUMANS; LACTAMS, MACROCYCLIC; MASS SPECTROMETRY; METHACRYLATES; MOLECULAR WEIGHT; OVARIAN NEOPLASMS; QUINONES; TUMOR CELLS, CULTURED;

EID: 0035816169 PISSN: 01683659 EISSN: None Source Type: Journal
DOI: 10.1016/S0168-3659(01)00318-2 Document Type: Conference Paper

Times cited : (50)

References (41)

1
- 0014968792
- Gedanamycin. I. Structure assignment
- (1970) J. Am. Chem. Soc. , vol.92 , pp. 7591-7593
- Sasaki, K.¹ Rinehart K.L., Jr.² Slomp, G.³ Grostic, M.F.⁴ Olson, E.C.⁵

2
- 0014847819
- Geldanamycin, a new antibiotic
- (1970) J. Antibiot. , vol.23 , pp. 442-447
- De Boer, C.¹ Meulman, P.A.² Wnuk, R.J.³ Peterson, D.H.⁴

3
- 0028064940
- Inhibition of heat shock proteins HSP90-pp60v-src heteroprotein complex formation by benzoquinone ansamaycins: Essential role for stress proteins in oncogenic transformation
- (1994) Proc. Natl. Acad. Sci. USA , vol.91 , pp. 8324-8328
- Whitesell, L.¹ Mimnaugh, E.G.² De Costa, B.³ Myers, C.E.⁴ Neckers, L.M.⁵

4
- 0029670034
- p185erbB2 binds to GRP94 in vivo. Dissociation of the p185erbB2/GRP94 heterocomplex by benzoquinone ansamycins precedes depletion of p185erbB2
- (1996) J. Biol. Chem. , vol.271 , pp. 4974-4977
- Chavany, C.¹ Mimnaugh, E.G.² Miller, P.³ Bitton, R.⁴ Nguyen, P.⁵ Trepel, J.⁶ Whitesell, L.⁷ Schnur, R.⁸ Moyer, J.D.⁹ Neckers, L.¹⁰

5
- 0029145215
- Geldanamycin selectively destabilize and comformationally alters mutated p53
- (1995) Oncogene , vol.11 , pp. 933-939
- Blagosklonny, M.V.¹ Toretsky, J.² Neckers, L.³

6
- 0028786332
- Disruption of the Raf-1-Hsp90 molecular complex results in destabilization of Raf-1 and loss of Raf-1-Ras association
- (1995) J. Biol. Chem. , vol.270 , pp. 24585-24588
- Schulte, T.W.¹ Blagosklonny, M.V.² Ingui, C.³ Neckers, L.⁴

7
- 0028233833
- Depletion of the erbB-2 gene product p185 by benzoquinoid ansamycins
- (1994) Cancer Res. , vol.54 , pp. 2724-2730
- Miller, P.¹ DiOrio, C.² Moyer, M.³ Schnur, R.C.⁴ Bruskin, A.⁵ Cullen, W.⁶ Moyer, J.D.⁷

8
- 0029122080
- Inhibition of the oncogene product p185erB-2 in vitro and in vivo by geldanamycin and dehydrogeldanamycin derivatives
- (1995) J. Med. Chem. , vol.38 , pp. 3806-3812
- Schnur, R.C.¹ Corman, M.L.² Gallaschun, R.J.³ Cooper, B.A.⁴ Dee, M.F.⁵ Doty, J.L.⁶ Muzzi, M.L.⁷ Moyer, J.D.⁸ DiOrio, C.I.⁹ Barbacci, E.G.¹⁰ Miller, P.E.¹¹ O'Brien, A.T.¹² Morin, M.J.¹³ Foster, B.A.¹⁴ Pollack, V.A.¹⁵ Savage, D.M.¹⁶ Sloan, D.E.¹⁷ Pustilnik, L.R.¹⁸ Moyer, M.P.¹⁹

9
- 0029123128
- erbB-2 Oncogene inhibition by geldanamycin derivatives: Synthesis, mechanism of action, and structure-activity relationships
- (1995) J. Med. Chem. , vol.38 , pp. 3813-3820
- Schnur, R.C.¹ Corman, M.L.² Gallaschun, R.J.³ Cooper, B.A.⁴ Dee, M.F.⁵ Doty, J.L.⁶ Muzzi, M.L.⁷ DiOrio, C.I.⁸ Barbacci, E.G.⁹ Miller, P.E.¹⁰ Pollack, V.A.¹¹ Savage, D.M.¹² Sloan, D.E.¹³ Pustilnik, L.R.¹⁴ Moyer, J.D.¹⁵ Moyer, M.P.¹⁶

10
- 0029056501
- Preclinical pharmacologic evaluation geldanamycin as an antitumor agent
- (1995) Cancer Chemother. Pharmacol. , vol.36 , pp. 305-315
- Supko, J.G.¹ Hickman, R.L.² Grever, M.R.³ Malspeis, L.⁴

11
- 0000076189
- Comparison of geldanamycin (NSC-330507D) toxicity in rats
- (1997) Proc. Am. Assoc. Cancer Res. , vol.38 , pp. 308
- Page, J.¹ Heath, J.² Fulton, R.³ Yalkowsky, E.⁴ Tabibi, E.⁵ Tamaszewski, J.⁶ Smith, A.⁷ Rodman, L.⁸

12
- 0032101569
- Metabolism of 17-(allylamino)-17-demethoxygeldanamycin (NSC330507) by murine and human hepatic preparations
- (1998) Cancer Res. , vol.58 , pp. 2385-2396
- Egorin, M.J.¹ Rosen, D.M.² Wolff, J.H.³ Callery, P.S.⁴ Musser, S.M.⁵ Eiseman, J.L.⁶

13
- 0000318466
- Plasma pharmacokinetics and tissue distribution of 17-allylaminogeldanamycin (NCS-330507), aprodrug for geldanamycin, in CD2F1 mice and Fisher 344 rats
- (1997) Proc. Am. Assoc. Cancer Res. , vol.38 , pp. 308
- Eiseman, J.L.¹ Sentz, D.L.² Zuhowski, E.G.³ Ramsland, T.S.⁴ Rosen, D.M.⁵ Reyna, S.P.⁶ Egorin, M.J.⁷

14
- 0031875042
- The benzoquinone ansamycin 17-allylamino-17-demethoxygeldanamycin binds to HSP90 and shares important biologic activities with delganamycin
- (1998) Cancer Chemother. Pharmacol. , vol.42 , pp. 273-279
- Schulte, T.W.¹ Neckers, L.M.²

15
- 0033579175
- DT-Diaphorase expression and tumor cell sensitivity to 17-allylamino,17-demethoxygeldanamycin, an inhibitor of heat shock protein 90
- (1999) J. Natl. Cancer Inst. , vol.91 , pp. 1940-1949
- Kelland, L.R.¹ Sharp, S.Y.² Rogers, P.M.³ Myers, T.G.⁴ Workman, P.⁵

16
- 0034655207
- Identification of a geldanamycin dimer that induces the selective degradation of HER-family tyrosine kinases
- (2000) Cancer Res. , vol.60 , pp. 2090-2094
- Zheng, F.F.¹ Kuduk, S.D.² Ciosis, G.³ Munster, P.N.⁴ Sepp-Lorenzino, L.⁵

17
- 0031693703
- The Hsp90 complex - A super-chaperone machine as a novel drug target
- (1998) Biochem. Pharmacol. , vol.56 , pp. 675-682
- Scheibel, T.¹ Buchner, J.²

18
- 0346551010
- Polymer conjugates with anticancer activity
- (1995) Adv. Polym. Sci. , vol.122 , pp. 55-123
- Putnam, D.¹ Kopeček, J.²

19
- 0041181628
- HPMA copolymer-anticancer drug conjugates: Design, activity, and mechanism of action
- (2000) Eur. J. Pharm. Biopharm. , vol.50 , pp. 61-81
- Kopeček, J.¹ Kopečková, P.² Minko, T.³ Lu, Z.-R.⁴

20
- 0022858683
- A new concept for macromolecular therapeutics in cancer therapy: Mechanism of tumoritropic accumulation of proteins and the antitumor agent SMANCS
- (1986) Cancer Res. , vol.46 , pp. 6387-6392
- Matsumura, Y.¹ Maeda, H.²

21
- 0031959490
- Early phase tumor accumulation of macromolecules: A great difference in clearance rate between tumor and normal tissues
- (1998) Jpn. J. Cancer Res. , vol.89 , pp. 307-314
- Noguchi, Y.¹ Wu, J.² Duncan, R.³ Strohalm, J.⁴ Ulbrich, K.⁵ Akaike, T.⁶ Maeda, H.⁷

22
- 0020682412
- Targeting of N-(2-hydroxypropyl)methacrylamide copolymer to liver by incorporation of galactose residues
- (1983) Biochim. Biophys. Acta , vol.755 , pp. 518-521
- Duncan, R.¹ Kopeček, J.² Rejmanová, P.³ Lloyd, J.B.⁴

23
- 0001319102
- N-(2-Hydroxypropyl)methacrylamide copolymers containing pendant saccharide moieties. Synthesis and bioadhesive properties
- (1991) J. Polym. Sci. Part A: Polym. Chem. , vol.29 , pp. 1895-1991
- Rathi, R.C.¹ Kopečková, P.² Říhová, B.³ Kopeček, J.⁴

24
- 0022379009
- Biological properties of targetable poly[N-(hydroxypropyl)methacrylamide]-antibody conjugates
- (1985) J. Control. Release , vol.2 , pp. 289-310
- Říhová, B.¹ Kopeček, J.²

25
- 0023930539
- Antibody directed affinity therapy applied to the immune system: In vivo effectiveness and limited toxicity of daunomycin conjugates to HPMA copolymers and targeting antibody
- (1988) Clin. Immunol. Immunopathol. , vol.46 , pp. 100-114
- Říhová, B.¹ Kopečková, P.² Strohalm, J.³ Rossmann, P.⁴ Vûtvička, V.⁵ Kopeček, J.⁶

26
- 0030042022
- HPMA copolymer-anticancer drug-OV-TL16 antibody conjugates. 1. Influence of the method of synthesis on the binding affinity to OVCAR-3 ovarian carcinoma cells in vitro
- (1996) J. Drug Target. , vol.3 , pp. 357-373
- Omelyanenko, V.¹ Kopečková, P.² Gentry, C.³ Shiah, J.-G.⁴ Kopeček, J.⁵

27
- 0032498552
- HPMA copolymer-anticancer drug-OV-TL16 antibody conjugates. 2. Processing in epithelial ovarian carcinoma cells in vitro
- (1996) Int. J. Cancer , vol.75 , pp. 600-608
- Omelyanenko, V.¹ Gentry, C.² Kopečková, P.³ Kopeček, J.⁴

28
- 0344146604
- Polymerizable Fab′ antibody fragments for targeting of anticancer drugs
- (1999) Nat. Biotechnol. , vol.17 , pp. 1101-1104
- Lu, Z.-R.¹ Kopečková, P.² Kopeček, J.³

29
- 0022002504
- Stability in rat plasma and serum of lysosomally degradable oligopeptide sequences in N-(2-hydroxypropyl)methacrylamide copolymers
- (1983) Biomaterials , vol.6 , pp. 45-48
- Rejmanová, P.¹ Kopeček, J.² Duncan, R.³ Lloyd, J.B.⁴

30
- 0000859980
- Polymers containing enzymatically degradable bonds 8. Degradation of oligopeptide sequences in N-(2-hydroxypropyl)methacrylamide copolymers by bovine spleen cathepcin B
- (1983) Makromol. Chem. , vol.184 , pp. 2009-2020
- Rejmanová, P.¹ Pohl, J.² Baudyš, M.³ Kostka, V.⁴ Kopeček, J.⁵

31
- 0032580444
- Targetable HPMA copolymer-adriamycin conjugates. Recognition, internalization, and subcellular fate
- (1998) J. Control. Release , vol.53 , pp. 25-37
- Omelyanenko, V.¹ Kopečková, P.² Gentry, C.³ Kopeček, J.⁴

32
- 0345367901
- HPMA copolymer bound adriamycin overcomes MDR1 gene encoded resistance in a human ovarian carcinoma cell line
- (1998) J. Control. Release , vol.54 , pp. 223-233
- Minko, T.¹ Kopečková, P.² Pozharov, V.³ Kopeček, J.⁴

33
- 0034049291
- Efficacy of chemotherapeutic action of HPMA copolymer bound adriamycin in a solid tumor model of ovarian carcinoma
- (2000) Int. J. Cancer , vol.86 , pp. 108-117
- Minko, T.¹ Kopečková, P.² Kopeček, J.³

34
- 0032766043
- Comparison of the anticancer effect of free and HPMA copolymer-bound adriamycin in human ovarian carcinoma cells
- (1999) Pharm. Res. , vol.16 , pp. 986-996
- Minko, T.¹ Kopečková, P.² Kopeček, J.³

35
- 49549170184
- Poly[N-(2-hydroxypropyl)methacrylamide] I. Radical polymerization and copolymerization
- (1973) Eur. Polym. J. , vol.9 , pp. 7-14
- Kopeček, J.¹ Bažilová, H.²

36
- 0000932483
- Aminolyses of monomeric and polymeric p-nitrophenyl esters of methacryloylated amino acids
- (1977) Makromol. Chem. , vol.178 , pp. 2159-2168
- Rejmanová, P.¹ Labský, J.² Kopeček, J.³

37
- 0004226645
- US Pat. 5 037 883 (6 August 1991)
- Synthetic polymeric drugs
- Kopeček, J.¹ Rejmanová, P.² Strohalm, J.³ Ulbrich, K.⁴ Říhová, B.⁵ Chytrý, V.⁶ Lloyd, J.B.⁷ Duncan, R.⁸

38
- 0024595042
- Re-examination and further development of precise and rapid dye method for measuring cell growing/cell kill
- (1989) J. Immunol. Methods , vol.119 , pp. 203-210
- Hansen, M.B.¹ Nielsen, S.E.² Berg, K.³

39
- 0034658560
- Synthesis and evaluation of antiproliferative activity of a geldanamycin-herceptin immunoconjugate
- (2000) Bioorg. Med. Chem. Lett. , vol.10 , pp. 1025-1028
- Mandler, R.¹ Dadachova, E.² Brechbiel, J.K.³ Waldmann, T.A.⁴ Brechbiel, M.W.⁵

40
- 0023450012
- w) of N-(2-hydroxypropyl)methacrylamide copolymers on body distribution and rate of excretion after subcutaneous, intraperitoneal, and intravenous administration to rats
- (1987) J. Biomed. Mater. Res. , vol.21 , pp. 1341-1358
- Seymour, L.W.¹ Duncan, R.² Strohalm, J.³ Kopeček, J.⁴

41
- 0017089608
- New types of synthetic infusion solutions. III. Elimination and retention of poly[N-(2-hydroxypropyl)methacrylamide] in a test organism
- (1976) J. Biomed. Mater. Res. , vol.10 , pp. 953-963
- Šprincl, L.¹ Exner, J.² Štěrba, O.³ Kopeček, J.⁴

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.